Tuesday, September 2, 2025

11:00 - 12:30

---

Details

Chair: Dr Rebecka Isaksson, FIP Scientific Secretary, UK Topics to be presented: - Drug delivery and manufacturing - New generation of pharmaceutical scientists - New medicines Presentations: RFTU-0101 - Paracetamol quantum dots: A revolutionary leap in nanomedicine and drug delivery Dr Gamze Camlik RFTU-0102 - FePt-incorporated metal–organic framework nanoparticles for drug delivery and sonodynamic therapy Mr David Hinolan RFTU-0103 - Synthesis, characterization, and biodistribution of boron-doped carbon quantum dots: Advancing biocompatible nanomaterials for targeted biomedical applications Mrs Gökçe Karaotmarlı Güven RFTU-0104 - Co-amorphous system of aprepitant and naringin: Enhanced solubility, bioavailability, and cytotoxicity for potential lung cancer treatment Ms Ekta Pardhi RFTU-0105 - Lactobacillus reuteri protects Parkinson's disease mice through attenuating BBB impairment mediated by VSMC apoptosis and inhibiting neuroinflammation Dr Zhe Zhao RFTU-0106 - Machine learning-based screening and identification of antimalarial compounds Mr Christopher Chiemerie Egemonye RFTU-0107 - Sugar-conjugated dithiocarbamates: A novel strategy to overcome chemoresistance in breast cancer Prof Mohammad Najlah RFTU-0108 - Desmodium gangeticum restores testicular health and enhances reproductive outcomes in multi-generational and age-related stress models Dr Vijay Chidrawar RFTU-0109 - Treatment modifiers and predictors of risperidone response in individuals with dementia: An individual participant meta-analysis of six randomised controlled trials Mr Trong Hieu Le RFTU-0110 - Physiologically based pharmacokinetic modeling of lamotrigine to predict drug-disposition using GastroPlusTM Dr Najia Rahim RFTU-0112 - Assessing UK pharmacists and pharmacy technicians’ knowledge, attitudes, and practice towards antibiotics, antibiotic use, and antibiotic resistance: A cross-sectional national survey of 1020 pharmacy professionals Prof Diane Ashiru-Oredope RFTU-0113 - Healthcare professionals’ and consumers’ awareness and understanding of the Black Triangle Scheme and its influence on adverse drug event reporting in Australia: A mixed-methods study Dr Eyob Alemayehu Gebreyohannes RFTU-0114 - Risk management by the marketing authorisation holder in product quality review Mr Jeremy Gauci

---

Speakers